Share

    


In This Section

Companies A-Z

Search for Assistance Programs

AstraZeneca

AstraZeneca offers the AstraZeneca Access 360™ for patients prescribed an AstraZeneca product. The program provides personal support to help streamline access and reimbursement for select AstraZeneca medicines.

For more information on Access 360, search the prescribed product in this Guide, go online, or call 1.844.275.2360, Monday through Friday, 8:00 AM to 8:00 PM EST, excluding holidays. 

Oncology-related products: Calquence® (acalabrutinib) capsules, Faslodex® (fulvestrant) injection, Imfinzi® (durvalumab) injection for intravenous use, Iressa® (gefitinib) tablets, Lynparza® (olaparib) tablets, Tagrisso® (osimertinib) tablets

Reimbursement Assistance

AstraZeneca Access 360™

Access 360 can assist healthcare providers and patients with:

  • Benefit investigation

  • Prior authorization support

  • Pharmacy research

  • Pharmacy coordination

  • Claims and appeal process support.

For more information, call 1.844.275.2360, Monday through Friday, 8:00 AM to 8:00 PM EST or visit myaccess360.com.

Independent Charitable Foundations/Organizations

AstraZeneca Access 360™ Referrals

Assistance may be available through independent foundations, such as those listed on the Access 360 website. Foundations can provide a variety of assistance types, like co-pay, transportation, premium, patient education, etc.

Co-Pay Card/Out-Of-Pocket Cost Assistance

AstraZeneca Patient Savings Programs

The goal of the AstraZeneca Patient Savings Programs is to assist eligible patients with their out-of-pocket costs. Most eligible patients will pay $0 per supply or infusion, dependent on the specific medication, and is subject to annual maximums. There are no income requirements to participate in these programs.

Patients are ineligible if prescriptions are paid by any state or other federally funded programs, including, but not limited to, Medicare Part B, Medicare Part D, Medicaid, Medigap, Veterans Affairs, or TriCare, or where prohibited by law. Eligibility rules apply. Offer is invalid for claims and transactions more than 120 days from the date of service.

How the Programs Work:

  1. Patients may have an out-of-pocket cost for an AstraZeneca specialty product.

  2. If the patient meets the eligibility requirements, healthcare professionals can enroll patients into the Patient Savings Program via the online enrollment portal. The links to the portal for each product can be found online.

  3. A Patient Savings Program account will be created for the eligible patient. Once enrolled, patient-specific account information will be presented in the portal for immediate use.

  4. The patient will pay a set amount of their out-of-pocket costs, based on the product. The pharmacy or healthcare provider will use the Patient Savings Program to cover the balance, up to the program maximum.

Program benefits/maximums include:

  • For Calquence, patients pay $0 per 30-day supply, up to a maximum of $26,000 per year.

  • For Faslodex, patients pay $0 per dose, up to a maximum of $6,000 per year. 

  • For Imfinzi, patients pay $0 per infusion, up to a maximum of $26,000 per year.

  • For Iressa, patients pay $0 per 28-day supply, up to a maximum of $26,000 per year.

  • For Lynparza, patients pay $0 per 30-day supply, up to a maximum of $26,000 per year.

  • For Tagrisso, patients pay $0 per 30-day supply, up to a maximum of $26,000 per year.

  • For Koselugo, patients pay $0 per 30-day supply, up to a maximum of $26,000 per year.

  • For Saphnelo, patients pay $0 per infusion, up to a maximum of $16,500 per calendar year.

  • For Fasenra, patients pay  $0 per injection, up to a maximum of $13,000 per calendar year.

  • For Imfinzi, patients pay $0 per infusion, up to a maximum of $26,000 per year. 

For more information about eligibility and details on these programs, visit the savings programs website or call 1.844.275.2360, Monday through Friday, 8:00 AM to 8:00 PM EST.

Patient Assistance Program

The AZ&Me™ Prescription Savings Program

The AZ&Me Prescription Savings Program is designed to help qualifying patients without insurance and those with Medicare who are still having trouble affording their AstraZeneca medications. There are two programs: The AZ&Me Prescription Savings program for people without insurance and the AZ&Me Prescription Savings program for people with Medicare.

There is a shared application process for the AZ&Me Prescription Savings Program for people without insurance and the AZ&Me Prescription Savings Program for people with Medicare, and the same application is used for both programs.

Eligibility Requirements:

  • Patient must be a resident of the United States.

  • Patient must not be currently receiving prescription drug coverage under a private insurance or government program (excluding Medicare), or receiving any other assistance to help pay for medicine.

  • Patient's annual income must be at or below a certain level.

  • If the patient is a Medicare beneficiary, they must not be eligible for or enrolled in Low Income Subsidy for Medicare Part D.

The following items must be submitted to complete the patient application:

  • A completed application, signed and dated by the patient and prescriber.

  • A completed prescription on page three of the application.

To apply for the program, patients and providers may either call 1.800.292.6363 or visit its website to begin the enrollment process online. Applications can also be faxed to 1.877.239.0867. For an updated list of the medications available through the AZ&Me Prescription Savings Program, visit the eligibility page.

Please note that faxed applications must be sent from a healthcare provider’s office in order for the prescription to be processed.

For more information, visit azandmeapp.com or call 1.800.292.6363.